There are many things we’ve learned from studying the ancient Egyptians. One especially fascinating discovery was evidence of ...

Tuberculosis remains a major health challenge in South Africa, but professional nurse Nhlanhla Mofokeng is determined to change that through education, compassion, and community support.

Tuberculosis. Read the latest research news on tuberculosis, including a quick new TB test, new TB treatment options, and the latest news on tuberculosis infections.

Through the model, TN aims to reduce the average time for TB patients from diagnosis to getting admitted to the hospital ...

Researchers have identified two new drug families that block a key tuberculosis (TB) enzyme, offering hope for novel ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

One of the major challenges in tuberculosis (TB) management is to identify the different stages of Mycobacterium tuberculosis (Mtb) infection. Although a quarter of the global population is estimated ...

Glucan-mediated trained immunity activates alveolar macrophages which exacerbates acute lung injury induced by LPS.

Their comparative genomic analysis with Mycobacterium tuberculosis and other M. tuberculosis complex members identifies extensive recombination and provides insights into the evolution of ...

Tuberculosis (TB) is a bacterial infection. It most commonly causes a lung infection after a period of no disease activity, with symptoms such as coughing, chest pain, and fatigue.

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

Boehringer drug scores in another pulmonary fibrosis trial Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings.